Gov. Greg Abbott met with local officials in Lubbock Thursday and provided an update on the distribution of bamlanivimab to acute care hospitals across every geographic region of the state, including hospitals in Lubbock.

Produced by the Eli Lilly & Company, bamlanivimab is a monoclonal antibody therapy for COVID-19 that has proven to be 95 percent effective in patients who have been infected with the virus.